Another Breakthrough– Asep Inc.’s A.I.-Based Sepsis Technology Identifies COVID-19 Severity from a Blood Sample

A recent study led by Asep Inc.’s Founder, Chair and CEO, Dr. Robert E. W. Hancock, concludes that there is hope for improved clinical management of COVID-19 patients by better assessing the severity of sepsis, a deadly disease that impacts many COVID-19 patients. VANCOUVER, BC, July 14,…